PT Modifier in Medical Billing: Medicare Guidelines, Coding Rules, and Examples for 2026 | Revex Square

PT Modifier in Medical Billing: Medicare Guidelines, Coding Rules, and Examples for 2026

Table of Contents

The PT modifier in medical billing identifies a colorectal cancer screening procedure that becomes diagnostic or therapeutic during the same clinical encounter. Medicare uses this HCPCS Level II modifier to indicate that a procedure originally began as a preventive screening, even when the physician subsequently performs a biopsy, polypectomy, or another qualifying intervention.

For gastroenterologists, outpatient facilities, and medical billing teams, correct PT modifier reporting helps Medicare process converted screening procedures under the appropriate cost-sharing rules.

In 2026, qualifying procedures reported with modifier PT have the Medicare Part B deductible waived, while the applicable beneficiary coinsurance is generally reduced to 15%.

This guide explains when modifier PT applies, which procedure codes are commonly involved, how to report it on Medicare claims, and what changes are scheduled for 2027 and beyond.

What Is Modifier PT in Medical Billing?

When to Use Modifier PT in Medical Billing: Medicare Guidelines, Polyp Removal, Biopsy, and Flexible Sigmoidoscopy Examples | Revex Square

“Modifier PT” means “colorectal cancer screening test; converted to diagnostic test or other procedure.”

Modifier PT a two-character HCPCS Level II modifier used in Medicare billing to indicate that a colorectal screening procedure changed because of findings or treatment performed during the examination.

For example, a patient arrives for a scheduled screening colonoscopy. During the procedure, the gastroenterologist discovers a polyp and removes it using a snare.

The completed procedure is no longer reported simply as a screening colonoscopy. Instead, the billing team reports the appropriate therapeutic colonoscopy code and appends modifier PT.

Modifier PT the original preventive purpose of the examination while accurately reporting the intervention performed.

Medicare Administrative Contractors (MACs) use this information to process the claim according to the applicable colorectal screening payment rules.

The CMS billing and coding guidance for converted screening colonoscopies explains how the appropriate procedure code and PT modifier should be reported.

When Should Modifier PT Be Used?

Modifier PT applies when an eligible colorectal cancer screening begins as a preventive service but becomes diagnostic or therapeutic during the examination.

The original reason for the procedure matters.

A screening colonoscopy is generally performed to look for colorectal cancer or precancerous changes in an eligible individual. A diagnostic colonoscopy, by contrast, investigates an existing clinical concern, such as rectal bleeding, unexplained iron-deficiency anemia, or another documented symptom.

Modifier PT does not turn a diagnostic procedure into a screening service. It preserves the screening classification when an originally planned preventive examination requires an additional intervention.

1. Screening Colonoscopy With Polyp Removal

A Medicare beneficiary undergoes a routine screening colonoscopy. The physician identifies a polyp and removes it using a snare.

The billing team reports the appropriate CPT code for the polypectomy, such as 45385-PT, when supported by the procedure documentation.

Modifier PT indicates that the colonoscopy started as screening and became therapeutic.

2. Screening Colonoscopy With Biopsy

During an otherwise routine screening colonoscopy, the physician identifies an abnormal area and obtains a tissue biopsy.

When the documented procedure supports CPT 45380, the Medicare claim may report 45380-PT.

Modifier PT communicates that the biopsy was performed during a procedure that originally had a screening purpose.

The physician’s report must support the screening indication, abnormal finding, and biopsy performed.

3. Screening Flexible Sigmoidoscopy With Intervention

Modifier PT is not limited to colonoscopy.

A screening flexible sigmoidoscopy may also become diagnostic or therapeutic when an unexpected finding requires an additional qualifying procedure.

The billing team should select the code representing the actual service and apply PT modifier where Medicare’s coding instructions require it.

When Modifier PT Should Not Be Used

A physician schedules a colonoscopy specifically to investigate persistent rectal bleeding.

Even if a polyp is discovered and removed, the examination began as diagnostic rather than preventive.

Modifier PT should not be appended merely because an intervention occurred.

The same principle applies to colonoscopies scheduled to investigate a known abnormality or clinical symptom. Coding depends on the documented reason for the examination and the service performed, not simply whether a polyp was present.

PT Modifier Guidelines for Medicare Claims

Correct use of modifier PT requires the billing team to review the physician’s original order, procedure report, diagnosis documentation, and Medicare claim requirements.

Confirm the Screening Indication Before Using Modifier PT

Before assigning modifier PT, confirm that the procedure was originally intended as a covered colorectal cancer screening.

The medical record should establish the preventive purpose of the examination.

For patients at increased colorectal cancer risk, the documentation should also support the applicable risk category and screening eligibility.

Select the Procedure Code Based on the Service Performed.

When a screening colonoscopy becomes therapeutic, the claim must reflect the actual intervention.

A polypectomy performed by snare technique, for example, is coded differently from a colonoscopy that includes a biopsy.

Using the original screening HCPCS code alone would not accurately describe the completed therapeutic procedure.

Append Modifier PT to the Appropriate Procedure Code

Modifier PT is appended to the diagnostic or therapeutic procedure code used to report the converted service.

For example:

45385-PT

The procedure code identifies the colonoscopy with snare removal, while PT modifier indicates that it began as a colorectal cancer screening.

Medicare also provides modifier PT instructions for certain associated anesthesia and other services. CMS identifies eligible code groups and services in its MLN Matters MM12656 guidance.

Assign Supported ICD-10-CM Diagnosis Codes

The diagnosis coding should accurately reflect the reason for screening and any findings documented during the encounter.

Commonly relevant codes include:

ICD-10-CM codeDescriptionApplication
Z12.11Encounter for screening for malignant neoplasm of the colonDocuments the screening indication
Z80.0Family history of malignant neoplasm of digestive organsMay support a qualifying family-history indication
Z15.060Genetic susceptibility to colorectal cancerMay apply when the documented genetic susceptibility meets coding requirements
K63.5Polyp of colonMay describe a documented polyp when appropriate

Do not assign a definitive diagnosis solely because a biopsy was performed. Diagnosis selection must follow the clinical documentation, available pathology findings, and applicable ICD-10-CM coding guidelines.

The order of diagnosis codes can also affect claim adjudication. Billing teams should follow the relevant MAC’s instructions when reporting screening indications alongside diagnostic findings.

Common CPT and HCPCS Codes Used With Modifier PT

The following table shows frequently encountered colorectal screening and converted-procedure codes.

CodeServiceModifier PT guidance
G0104Screening for flexible sigmoidoscopyOriginal screening service; report the converted procedure as applicable
G0105Screening colonoscopy for a high-risk individualOriginal screening code; use the appropriate converted procedure code when intervention occurs.
G0121Screening colonoscopy for an individual not meeting high-risk criteriaOriginal screening code; use the appropriate converted procedure code when intervention occurs.
45378Diagnostic colonoscopyPT only when the documented circumstances support conversion from screening
45380Colonoscopy with biopsyPT may apply when a screening becomes diagnostic.
45384Colonoscopy with lesion removal using hot biopsy forcepsPT may apply when an eligible screening becomes therapeutic.
45385Colonoscopy with snare removalPT may apply when an eligible screening becomes therapeutic.
00811Anesthesia for a qualifying lower intestinal endoscopic procedureFollow Medicare’s specific modifier and billing rules.

The applicable code depends on the service documented, and modifiers must be supported by the claim circumstances.

Billing teams should not automatically append the PT modifier to every colonoscopy code or every associated service. They should check the current CPT/HCPCS definitions and payer instructions before submission.

Modifier PT Billing Examples

The PT modifier rules become clearer when you review actual coding situations

Example 1: Screening Colonoscopy Converted to Polypectomy

Clinical scenario: A 67-year-old Medicare beneficiary presents for a scheduled colorectal cancer screening. During the colonoscopy, the gastroenterologist identifies a polyp in the sigmoid colon and removes it with a snare.

Coding approach:

  • Procedure: CPT 45385
  • Modifier: PT
  • Claim example: 45385-PT
  • Diagnosis: Appropriate documented screening indication and polyp finding

The physician’s report should describe the original screening indication, lesion location, removal method, and relevant findings.

The applicable Medicare cost-sharing reduction can then be considered during claim adjudication.

Example 2: Screening Colonoscopy With Tissue Biopsy

Clinical scenario: A 72-year-old Medicare beneficiary undergoes a screening colonoscopy. An abnormal area is identified, and the physician performs a biopsy.

Coding approach:

  • Procedure: CPT 45380, when supported
  • Modifier: PT
  • Claim example: 45380-PT

The claim reports the biopsy while retaining the screening-to-diagnostic conversion information.

Example 3: Colonoscopy Ordered for Rectal Bleeding

Clinical scenario: A patient presents with rectal bleeding and undergoes a colonoscopy to determine the cause. The physician discovers and removes a polyp.

Coding approach: Report the appropriate diagnostic or therapeutic procedure code without PT.

Although a polypectomy occurred, the examination was diagnostic from the beginning.

Modifier PT is not appropriate.

Example 4: Screening Colonoscopy Without Intervention

Clinical scenario: An eligible Medicare beneficiary undergoes a routine screening colonoscopy. No biopsy or therapeutic intervention is necessary.

Coding approach: Report G0105 or G0121, as appropriate for the beneficiary’s risk category and coverage circumstances.

Modifier PT is not needed because the examination remained a screening procedure.

These examples are illustrative. Actual claim coding must reflect the physician’s report, current code descriptors, and applicable Medicare contractor guidance.

Medicare Modifier PT Reimbursement Rules in 2026

RevexSquare Medicare Modifier PT reimbursement rules for 2026, featuring deductible waiver and 15% coinsurance.

One of the most important aspects of modifier PT is its effect on Medicare beneficiary cost-sharing.

When a covered colorectal screening becomes a qualifying diagnostic or therapeutic procedure, Medicare applies special cost-sharing rules to claims with modifier PT.

For calendar year 2026, the Part B deductible is waived and the applicable coinsurance is reduced to 15%.

This does not mean every converted procedure is entirely free to the beneficiary.

CMS has established a phased reduction in coinsurance for qualifying procedures associated with colorectal cancer screening.

Date of serviceBeneficiary coinsurancePart B deductible
2023–202615%Waived
2027–202910%Waived
January 1, 2030 onward0%Waived

These percentages apply to qualifying services under Medicare’s converted colorectal screening policy.

The changes are detailed in CMS MLN Matters MM12656.

For a gastroenterology practice or ASC, this distinction matters during eligibility verification, patient financial counseling, claim submission, and payment posting.

A patient may have no cost-sharing for an uncomplicated covered screening colonoscopy but owe the applicable reduced coinsurance when a qualifying intervention is performed.

Actual patient responsibility also depends on other coverage, claim circumstances, and Medicare payment rules.

Modifier PT vs. Modifier 33: What’s the Difference?

Modifier PT and modifier 33 both relate to preventive services, but they are not interchangeable.

Modifier PT is used under Medicare’s colorectal screening conversion policy. Modifier 33 identifies qualifying preventive services and is commonly used on applicable commercial insurance claims.

FeatureModifier PTModifier 33
Code classificationHCPCS Level IICPT modifier
Primary purposeIdentifies a colorectal screening converted to diagnostic or therapeutic careIdentifies qualifying preventive services
Typical payer applicationOriginal MedicareCommercial preventive-service claims
Common colorectal scenarioScreening colonoscopy with polypectomyEligible preventive colonoscopy under commercial coverage
Cost-sharing treatmentMedicare’s phased coinsurance policyDepends on applicable preventive coverage rules and payer policy

For example, a physician performs a screening colonoscopy and removes a polyp.

Under Original Medicare, 45385 with modifier PT (45385-PT) may be appropriate.

For an eligible commercial preventive service, 45385-33 may be appropriate under the plan’s policy.

Medicare Advantage and other payer arrangements require separate verification. Billing teams should not assume commercial rules automatically apply to every non-Original-Medicare claim.

Modifier PT vs. Modifier KX for Colorectal Screening

Modifier KX serves a different function from modifier PT.

Medicare expanded its definition of a complete colorectal cancer screening to include a qualifying follow-on screening colonoscopy after a positive covered noninvasive stool-based screening test.

In this situation, the practitioner may need to apply modifier KX to the applicable screening colonoscopy claim to indicate that the expanded screening requirements have been met.

For example, a beneficiary has a positive covered fecal immunochemical test (FIT), followed by a qualifying screening colonoscopy.

When the colonoscopy remains a screening service, the appropriate screening HCPCS code with KX may be required.

Modifier PT addresses a different event: the screening procedure becomes diagnostic or therapeutic during the encounter.

If both a prior positive noninvasive screening test and a subsequent intervention are involved, the billing team should review the current CMS and MAC instructions for the exact claim lines and modifiers.

Do not automatically substitute KX for PT or append both modifiers without confirming the correct claim-reporting requirements.

CMS explains the follow-on screening policy in MLN Matters MM13017.

Common PT Modifier Billing Mistakes

Gastroenterology billing teams can avoid many modifier-related problems by checking the following issues before submission.

Reporting Modifier PT on a Procedure That Began as Diagnostic

This is a frequent classification error.

The presence of a polyp does not determine whether PT applies. The original screening indication must be supported by the physician’s documentation.

Selecting the Wrong Procedure Code

A screening colonoscopy that becomes therapeutic must be reported according to the actual service performed.

The claim should not misrepresent a snare polypectomy as a biopsy or an uncomplicated screening.

Assuming Modifier PT Eliminates All Patient Costs

Modifier PT does not automatically eliminate coinsurance.

For qualifying procedures performed in 2026, the applicable Medicare coinsurance is 15%.

Failing to account for this rule may result in inaccurate patient estimates or billing adjustments.

Missing Screening Documentation

A procedure note that describes the intervention but fails to establish the original screening indication can make claim validation difficult.

Clinical documentation should make the sequence clear: the reason the procedure began, the finding encountered, and the intervention performed.

Applying Commercial Insurance Rules to Medicare

Modifier 33 and modifier PT serve different payment and reporting purposes.

The payer, benefit category, and clinical circumstances should be verified before assigning either modifier.

How to Improve PT Modifier Claim Accuracy

For gastroenterology practices, hospitals, and ASCs, reliable modifier PT billing depends on cooperation between clinical staff, coders, and revenue cycle teams.

A practical workflow begins before the procedure.

Before the examination: Verify Medicare eligibility, screening history, the physician’s order, risk category, and whether the service is preventive or diagnostic.

During documentation: Record the original screening indication, endoscopic findings, location of any abnormality, intervention performed, and relevant clinical details.

During coding: Select the CPT/HCPCS code representing the completed procedure. Apply PT only where supported and assign the appropriate diagnosis codes.

Before claim submission: Check modifier placement, claim edits, medical necessity requirements, associated service coding, and current Medicare contractor instructions.

After adjudication: Review denials, payment adjustments, and patient responsibility to identify errors that require correction.

Practices with recurring gastroenterology claim issues may benefit from a focused coding review. The objective is not simply to increase the number of claims submitted, but to ensure that each claim reflects the documented service and applicable Medicare payment requirements.

How PT Modifier Errors Affect Revenue Cycle Management

RevexSquare infographic showing how PT modifier errors cause claim denials, payment delays, increased administrative work, and reduced revenue.

Modifier-related errors can create work beyond the original coding process.

An incorrectly reported screening conversion may require the billing team to investigate claim adjudication, correct coding, reconcile patient responsibility, or submit a corrected claim.

For outpatient facilities, the issue may involve more than the physician’s professional claim. Facility billing and associated services may also require review under the applicable Medicare rules.

A consistent coding workflow helps practices identify problems before claims reach the payer.

Medical coding quality reviews should assess the screening indication, performed procedure, modifier selection, diagnosis assignment, and any relevant anesthesia or facility claim lines.

Accurate documentation and coding support compliant billing and reduce avoidable rework. They do not guarantee payment, because coverage, medical necessity, eligibility, and other claim requirements still apply.

Frequently Asked Questions About Modifier PT

What is the PT modifier used for?

Modifier PT indicates that a colorectal cancer screening procedure began as preventive screening and became diagnostic or therapeutic during the encounter. It is used under Medicare’s colorectal screening billing rules.

Is modifier PT used for all colonoscopies?

No. Modifier PT is appropriate only when the procedure meets Medicare’s screening-to-diagnostic or therapeutic conversion requirements. A colonoscopy originally ordered for diagnostic purposes does not qualify merely because an intervention is performed.

Can modifier PT be used with CPT 45385?

Yes. When a qualifying Medicare screening colonoscopy becomes a snare polypectomy, CPT 45385 may be reported with modifier PT, provided the documentation supports the service.

Can modifier PT be used with CPT 45380?

Yes. CPT 45380 may be reported with PT when a covered screening colonoscopy becomes a diagnostic procedure involving a biopsy and the applicable coding requirements are met.

Does modifier PT waive the Medicare deductible?

Yes. The Medicare Part B deductible is waived for qualifying converted colorectal screening procedures under the applicable rules.

Does Medicare pay 100% when modifier PT is used?

Not necessarily. For qualifying dates of service in 2026, the applicable beneficiary coinsurance is generally 15%, even though the deductible is waived. The coinsurance is scheduled to decrease to 10% in 2027–2029 and reach zero in 2030.

What is the difference between modifier PT and modifier 33?

Modifier PT identifies colorectal screening procedures converted to diagnostic or therapeutic services under Medicare’s rules. Modifier 33 identifies qualifying preventive services and is commonly used for commercial insurance billing.

Is modifier PT the same as modifier KX?

No. PT reports a colorectal screening conversion. KX is used in certain Medicare follow-on screening colonoscopy circumstances, including qualifying colonoscopies following positive covered noninvasive colorectal screening tests.

Can an ASC use modifier PT?

Yes, when the claim and procedure meet the relevant Medicare requirements. ASCs should verify the applicable facility coding and payment instructions rather than assuming professional and facility claims are always reported identically.

What documentation is needed for modifier PT?

The record should support the original screening indication, findings during the examination, the diagnostic or therapeutic service performed, and the diagnoses reported. The billing team should also verify any applicable Medicare coverage and contractor requirements.

Final Thoughts

Modifier PT plays an important role in Medicare colorectal screening claims because it identifies procedures that began as preventive examinations but required diagnostic or therapeutic intervention.

For medical practices and outpatient facilities, accurate coding begins with the original reason for the procedure. The physician’s documentation must support the intervention, and the billing team must select the correct procedure code and modifier.

The Medicare cost-sharing rules also require attention. In 2026, qualifying converted colorectal screening procedures retain a reduced 15% coinsurance, despite the waiver of the Part B deductible.

Regular reviews of coding practices, clinical documentation, and Medicare updates can help gastroenterology providers maintain accurate claims and reduce avoidable billing errors.

Need Help With Medical Coding and Billing?

Revex Square supports healthcare providers with medical coding, billing, and denial management services.

Our team can help practices review coding workflows, identify documentation gaps, and strengthen the accuracy of claims submitted to insurance payers.

Explore our medical coding services or denial management services to learn how we support healthcare revenue cycle operations.


Official References

  1. CMS — Billing and Coding: Screening Colonoscopy Converted to a Diagnostic and/or Therapeutic Colonoscopy (A55069)
  2. CMS — MLN Matters MM12656: Changes to Coinsurance for Related Procedures
  3. CMS — MLN Matters MM13017: Expansion of Colorectal Cancer Screening Coverage
  4. CMS — National Coverage Determination 210.3: Colorectal Cancer Screening Tests
  5. Medicare — Screening Colonoscopy Coverage

Need Medical Billing Help?

Our experts help clinics improve revenue cycle management and reduce claim denials.

Free Consultation

    Looking For A Medical
    Billing Quote